Current treatment approaches for NK/T-cell lymphoma-Reference-Cited by-同舟云学术

Current treatment approaches for NK/T-cell lymphoma

Published:2017 Issue:3 Volume:57 Page:98-108
ISSN:1346-4280
Container-title:Journal of Clinical and Experimental Hematopathology
language:en
Short-container-title:J Clin Exp Hematopathol

Author:

Yamaguchi Motoko¹,Miyazaki Kana¹

Affiliation:

1. Department of Hematology and Oncology, Mie University Graduate School of Medicine

Publisher

Japanese Society for Lymphoreticular Tissue Research

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jslrt/57/3/57_17018/_pdf

Reference77 articles.

1. 1 Swerdlow SH, Campo E, Harris NL, et al.: WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, IARC, 2008

2. 2 Yamaguchi M: Current and future management of NK/T-cell lymphoma based on clinical trials. Int J Hematol 96:562-571, 2012

3. 3 Oshimi K: Progress in understanding and managing natural killer-cell malignancies. Br J Haematol 139:532-544, 2007

4. 4 Liang R: Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type. Br J Haematol 147:13-21, 2009

5. 5 Au WY, Weisenburger DD, Intragumtornchai T, et al.: Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood 113:3931-3937, 2009

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS;Mediterranean Journal of Hematology and Infectious Diseases;2024-04-30

2. Targeting Bcl-xL is a potential therapeutic strategy for extranodal NK/T cell lymphoma;iScience;2023-08

3. PET/CT Imaging in Treatment Planning and Surveillance of Sinonasal Neoplasms;Cancers;2023-07-25

4. Long-term survival by surgery and adjuvant chemotherapy in a patient with perforated extranodal NK/T-cell lymphoma of the small intestine: a retrospective case study;Surgical Case Reports;2023-06-12

5. T-cell dysfunction in natural killer/T-cell lymphoma;OncoImmunology;2023-05-24